Literature DB >> 3403594

The incidence of cancer following total hip replacement.

W J Gillespie1, C M Frampton, R J Henderson, P M Ryan.   

Abstract

We have studied the incidence of tumours at remote sites following total hip replacement: 1,358 individuals have been followed up for 14,286 person-years after operation. In the decade following implantation the incidence of tumours of the lymphatic and haemopoietic systems was significantly greater, and that of cancer of the breast, colon, and rectum, significantly less than expected. Whilst the association might be due in part to an effect of the prosthetic implants, other mechanisms, particularly drug therapy, require consideration.

Entities:  

Mesh:

Year:  1988        PMID: 3403594

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  26 in total

1.  In vitro reactivity to implant metals demonstrates a person-dependent association with both T-cell and B-cell activation.

Authors:  Nadim James Hallab; Marco Caicedo; Rachel Epstein; Kyron McAllister; Joshua J Jacobs
Journal:  J Biomed Mater Res A       Date:  2010-02       Impact factor: 4.396

2.  Highly enhanced compatibility of human brain vascular pericyte cells on monolayer graphene.

Authors:  Jangheon Kim; Soohyun Kim; Wonsuk Jung
Journal:  Bioengineered       Date:  2016-09-30       Impact factor: 3.269

3.  Carcinogenicity of implantable materials: experimental and epidemiological evidence.

Authors:  David F Williams
Journal:  Int Urogynecol J       Date:  2014-03-11       Impact factor: 2.894

Review 4.  Development of malignant lymphoma after metal-on-metal hip replacement: a case report and review of the literature.

Authors:  C L McCarthy; Y Uchihara; M Vlychou; G Grammatopoulos; N A Athanasou
Journal:  Skeletal Radiol       Date:  2017-03-11       Impact factor: 2.199

Review 5.  Systemic effects of implanted prostheses made of cobalt-chromium alloys.

Authors:  R Michel; M Nolte; M Reich; F Löer
Journal:  Arch Orthop Trauma Surg       Date:  1991       Impact factor: 3.067

6.  Remodeling of large bone defects in the treatment of space-occupying lesions. Curettage without bone graft for treating benign bone tumors.

Authors:  M Chigira; H Watanabe; S Arita; K Noda; T Shimizu; T Shinozaki; M Nagase
Journal:  Arch Orthop Trauma Surg       Date:  1992       Impact factor: 3.067

7.  Soft tissue malignant lymphoma at sites of previous surgery.

Authors:  J M Radhi; K Ibrahiem; T al-Tweigeri
Journal:  J Clin Pathol       Date:  1998-08       Impact factor: 3.411

8.  Cancer risk is not increased after conventional hip arthroplasty.

Authors:  Tuomo Visuri; Pekka Pulkkinen; Pekka Paavolainen; Eero Pukkala
Journal:  Acta Orthop       Date:  2010-02       Impact factor: 3.717

9.  Graphene coatings for biomedical implants.

Authors:  Ramakrishna Podila; Thomas Moore; Frank Alexis; Apparao Rao
Journal:  J Vis Exp       Date:  2013-03-01       Impact factor: 1.355

10.  Blood transfusion, anesthesia, surgery and risk of non-Hodgkin lymphoma in a population-based case-control study.

Authors:  James R Cerhan; Eric A Engels; Wendy Cozen; Scott Davis; Richard K Severson; Lindsay M Morton; Gloria Gridley; Patricia Hartge; Martha Linet
Journal:  Int J Cancer       Date:  2008-08-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.